Leerink Partners Reiterates Market Perform Rating on Amylyx Pharmaceuticals inc. (AMLX)
Tweet Send to a Friend
Leerink Partners analyst Marc Goodman reiterated a Market Perform rating and $4.00 price target on Amylyx Pharmaceuticals inc. (NASDAQ: AMLX).The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
